name:  [known lastname 17298], [known firstname ]                     unit no:  [numeric identifier 17299]admission date:  [2148-3-25]     discharge date:  [2148-4-9]date of birth:   [2097-9-27]     sex:  mservice:  transplant surgery.  #58addendum:the patient was anticipating discharge to the [hospital 17300]rehabilitation center on [2148-4-4].  however, the patientwas found to have rising liver function tests with a peaktotal bilirubin level of 4.5 and, therefore, underwent anendoscopic retrograde cholangiopancreatography procedure onthis date.  this study demonstrated diffuse dilatation at theproximal site of the biliary anastomosis, compatible with ananastomotic stricture.  a 5 cm by #10 french plastic biliarystent was, therefore, placed.following this procedure, the patient felt well clinicallywithout abdominal pain.  however, his amylase and lipase wereslightly elevated the day following the procedure and he was,therefore, monitored for possible post endoscopic retrogradecholangiopancreatography pancreatitis.  the patient wasmaintained on his intravenous diuretics and his liverfunction tests slowly returned to [location 1867] following theprocedure.  however, on hospital day number 13, the patientcomplained of left upper extremity swelling, which he stateshad been there for some months prior to admission.  however,given the presence of a left subclavian central venous line,and this new finding on examination, a duplex ultrasound wasordered for the left upper extremity which was consistentwith a deep venous thrombosis.  the patient was, therefore,started on a heparin drip to be titrated to a goal pttbetween 40 to 60 seconds. he was also started on coumadin 5mg daily towards a goal inr of 2.0 to 2.5.  at this time, thepatient was progressing well with physical therapy and wasdischarged to the [hospital 17300] rehabilitation center on hospitalday number 16, on a heparin drip, along with intravenouslasix and coumadin.  his central venous line was removedprior to discharge.  his heparin drip may be discontinuedonce his inr reaches a level of 2.0.  he should be treatedfor coumadin for three months given his left upper extremitydeep vein thrombosis.  he will maintain his lasix dose at 80mg intravenous twice a day until his follow-up appointment on[2148-4-18].  he is to have his laboratory studies drawntwice weekly, on monday and thursday, and faxed to thetransplant center for adjustment of his cyclosporin dosing.this level is to be drawn two hours after his morning dose.the patient was instructed to call the transplant center ifhe had any other questions or concerns.                          [first name11 (name pattern1) ] [last name (namepattern4) 51], m.d.,ph.d.[md number(3) 9110]dictated by:[last name (namepattern1) 7438]medquist36d:  [2148-4-9]  06:13t:  [2148-4-9]  06:16job#:  [job number 17301]